ID

33478

Beschrijving

Impact of EPA and DHA Supplementation on Plasma Biomarkers of Inflammation (n3); ODM derived from: https://clinicaltrials.gov/show/NCT01810003

Link

https://clinicaltrials.gov/show/NCT01810003

Trefwoorden

Versies (1)
  1. 10-12-18 10-12-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

10 december 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Cardiovascular Disease, Inflammation NCT01810003

Engels

Eligibility Cardiovascular Disease, Inflammation NCT01810003

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
men and women aged between 18 and 70 years with metabolic syndrome as defined by the international diabetes federation (idf) criteria
Beschrijving

Age | Metabolic Syndrome

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0524620
stable body weight for at least 3 months prior to randomization.
Beschrijving

Stable body weight

Datatype

boolean

Alias
UMLS CUI [1]
C0517386
pre-menopausal women with regular menstrual cycle (25-35 days)
Beschrijving

Premenopausal state | Menstrual cycles regular

Datatype

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C2229012
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
plasma crp > 10 g/ml at screening
Beschrijving

Plasma C-reactive protein measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0428493
extreme dyslipidemias such as familial hypercholesterolemia
Beschrijving

Dyslipidemias Extreme | Hypercholesterolemia, Familial

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242339
UMLS CUI [1,2]
C0205403
UMLS CUI [2]
C0020445
previous history of cardiovascular disease (coronary heart disease, cerebrovascular disease or peripheral arterial disease) and type 1 or 2 diabetes or patients having received or being treated with insulin or a thiazolidinedione within the past 6 months
Beschrijving

Cardiovascular Disease | Coronary heart disease | Cerebrovascular Disorder | Peripheral Arterial Disease | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Insulin | Thiazolidinediones

Datatype

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0010068
UMLS CUI [3]
C0007820
UMLS CUI [4]
C1704436
UMLS CUI [5]
C0011854
UMLS CUI [6]
C0011860
UMLS CUI [7]
C0021641
UMLS CUI [8]
C1257987
subjects taking medications known to affect inflammation and blood lipids (e.g. steroids, beta blockers, thiazide diuretics, lipid lowering agents, hormone replacement, binging alcohol)
Beschrijving

Pharmaceutical Preparations Affecting Inflammation | Pharmaceutical Preparations Affecting Blood lipids | Steroids | Adrenergic beta-1 Receptor Antagonists | Thiazide Diuretics | Hypolipidemic Agents | Hormone replacement therapy | Alcohol intake above recommended sensible limits

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0021368
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0596192
UMLS CUI [3]
C0038317
UMLS CUI [4]
C0304516
UMLS CUI [5]
C0012802
UMLS CUI [6]
C0086440
UMLS CUI [7]
C0282402
UMLS CUI [8]
C0560219
subjects taking lcn-3pufa supplements within 6 months of study onset.
Beschrijving

Long chain n-3 PUFA Supplements

Datatype

boolean

Alias
UMLS CUI [1,1]
C0522095
UMLS CUI [1,2]
C0015689
UMLS CUI [1,3]
C0242295
Terug naar het begin van de pagina

Similar models

Eligibility Cardiovascular Disease, Inflammation NCT01810003

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age | Metabolic Syndrome
Item
men and women aged between 18 and 70 years with metabolic syndrome as defined by the international diabetes federation (idf) criteria
boolean
C0001779 (UMLS CUI [1])
C0524620 (UMLS CUI [2])
Stable body weight
Item
stable body weight for at least 3 months prior to randomization.
boolean
C0517386 (UMLS CUI [1])
Premenopausal state | Menstrual cycles regular
Item
pre-menopausal women with regular menstrual cycle (25-35 days)
boolean
C0232969 (UMLS CUI [1])
C2229012 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Plasma C-reactive protein measurement
Item
plasma crp > 10 g/ml at screening
boolean
C0428493 (UMLS CUI [1])
Dyslipidemias Extreme | Hypercholesterolemia, Familial
Item
extreme dyslipidemias such as familial hypercholesterolemia
boolean
C0242339 (UMLS CUI [1,1])
C0205403 (UMLS CUI [1,2])
C0020445 (UMLS CUI [2])
Cardiovascular Disease | Coronary heart disease | Cerebrovascular Disorder | Peripheral Arterial Disease | Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Insulin | Thiazolidinediones
Item
previous history of cardiovascular disease (coronary heart disease, cerebrovascular disease or peripheral arterial disease) and type 1 or 2 diabetes or patients having received or being treated with insulin or a thiazolidinedione within the past 6 months
boolean
C0007222 (UMLS CUI [1])
C0010068 (UMLS CUI [2])
C0007820 (UMLS CUI [3])
C1704436 (UMLS CUI [4])
C0011854 (UMLS CUI [5])
C0011860 (UMLS CUI [6])
C0021641 (UMLS CUI [7])
C1257987 (UMLS CUI [8])
Pharmaceutical Preparations Affecting Inflammation | Pharmaceutical Preparations Affecting Blood lipids | Steroids | Adrenergic beta-1 Receptor Antagonists | Thiazide Diuretics | Hypolipidemic Agents | Hormone replacement therapy | Alcohol intake above recommended sensible limits
Item
subjects taking medications known to affect inflammation and blood lipids (e.g. steroids, beta blockers, thiazide diuretics, lipid lowering agents, hormone replacement, binging alcohol)
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0021368 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0596192 (UMLS CUI [2,3])
C0038317 (UMLS CUI [3])
C0304516 (UMLS CUI [4])
C0012802 (UMLS CUI [5])
C0086440 (UMLS CUI [6])
C0282402 (UMLS CUI [7])
C0560219 (UMLS CUI [8])
Long chain n-3 PUFA Supplements
Item
subjects taking lcn-3pufa supplements within 6 months of study onset.
boolean
C0522095 (UMLS CUI [1,1])
C0015689 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial